Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.17 USD | +1.44% |
|
+1.18% | -11.62% |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.62% | 2.29B | |
+40.28% | 53.67B | |
+33.67% | 38.86B | |
-7.81% | 38.76B | |
-10.77% | 27.27B | |
+12.03% | 25.91B | |
-17.58% | 20.29B | |
+34.61% | 12.78B | |
+29.94% | 12.18B | |
-2.99% | 11.96B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Sector Update: Health Care Stocks Slipping in Late Slump